Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / NONOF - Genmab: Still A Rising Star In Biotech But Legal Dispute May Slow Down Growth Trajectory In The Near Term

NONOF - Genmab: Still A Rising Star In Biotech But Legal Dispute May Slow Down Growth Trajectory In The Near Term

Novo-Nordisk A/S
  • Genmab has continued to make great progress since my initial coverage a year ago.
  • The company's portfolio of current and future therapeutics in association with world-class partners bodes well for continued breakthroughs in the fight against cancer.
  • However, one issue of concern must be recognized and dealt with by both current and potential investors.

For further details see:

Genmab: Still A Rising Star In Biotech, But Legal Dispute May Slow Down Growth Trajectory In The Near Term
Stock Information
Company Name: Novo-Nordisk A/S
Stock Symbol: NONOF
Market: OTC
Website: novonordisk.com
Menu
NONOF NONOF Quote NONOF Short NONOF News NONOF Articles NONOF Message Board
Get NONOF Alerts

News, Short Squeeze, Breakout and More Instantly...